Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 20.8% in April

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Rating) was the recipient of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 4,500,000 shares, a drop of 20.8% from the April 15th total of 5,680,000 shares. Based on an average daily volume of 1,880,000 shares, the […]

Related Keywords

Johnp Butler , ,Hightower Advisors ,Akebia Therapeutics Inc ,Connor Clark Lunn Investment Management Ltd ,Akebia Therapeutics Company Profile ,Mirabella Financial Services ,Nasdaq ,Akebia Therapeutics ,Get Rating ,Financial Services ,Tower Advisors ,Connor Clark ,Lunn Investment Management ,Therapeutics Stock Down ,Akebia Therapeutics Daily ,Nasdaq Akba ,Nakba ,Medical ,Stocks ,Options ,Put ,Call ,